These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7958464)

  • 21. Food and Drug Administration Modernization Act of 1997; list of documents issued by the Food and Drug Administration that apply to medical devices regulated by the Center for Biologics Evaluation and Research. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Apr; 64(79):20312-3. PubMed ID: 10558481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [DNA cloning of Ad7 vaccine strain and sequence analysis of its Sma I H fragment].
    Zhou J; Qu J; Shi C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):23-5. PubMed ID: 12515165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
    Brandler S; Tangy F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Regulatory Evaluation of Vaccines for Human Use.
    Baylor NW
    Methods Mol Biol; 2016; 1404():773-787. PubMed ID: 27076337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks and benefits of vaccinia-vectored vaccine from the regulatory perspective.
    Marcus-Sekura CJ; Quinnan GV
    Res Virol; 1989; 140(5):467-9; discussion 487-91. PubMed ID: 2685956
    [No Abstract]   [Full Text] [Related]  

  • 27. Bluetongue vaccines: the past, present and future.
    Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
    Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines.
    Avakian AP; Poston RM; Kong FK; Van Kampen KR; Tang DC
    Expert Rev Vaccines; 2007 Jun; 6(3):457-65. PubMed ID: 17542759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of current preclinical testing strategies for bacterial vaccines.
    Falk LA; Chandler DK; Richman P
    Dev Biol Stand; 1998; 95():25-9. PubMed ID: 9855411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiviral vaccines].
    Girard M
    Med Trop (Mars); 1999; 59(4 Pt 2):522-6. PubMed ID: 10901858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facility.
    Grilley BJ; Gee AP
    Cytotherapy; 2003; 5(3):197-207. PubMed ID: 12850787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alphavirus-based vaccines.
    Lundstrom K
    Curr Opin Mol Ther; 2002 Feb; 4(1):28-34. PubMed ID: 11883692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologicals and vaccines: regulatory perspectives.
    Petricciani JC
    Dev Biol Stand; 1986; 63():15-9. PubMed ID: 3743903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant vector vaccines in vaccinology.
    Hilleman MR
    Dev Biol Stand; 1994; 82():3-20. PubMed ID: 7958480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing an approach to evaluate the use of neoplastic cells as vaccine substrates.
    Lewis AM
    Dev Biol (Basel); 2001; 106():37-42; discussion 42-3. PubMed ID: 11761251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory issues for plant-made pharmaceuticals and vaccines.
    Streatfield SJ
    Expert Rev Vaccines; 2005 Aug; 4(4):591-601. PubMed ID: 16117714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.